Innate Pharma SA Increase Decrease In Net Defined Benefit Liability Asset Resulting From Miscellaneous Other Changes
Innate Pharma SA (IPHA) reported Increase Decrease In Net Defined Benefit Liability Asset Resulting From Miscellaneous Other Changes of -EUR 851.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromMiscellaneousOtherChanges · last filed 2026-04-01
| Period end | Increase Decrease In Net Defined Benefit Liability Asset Resulting From Miscellaneous Other Changes 12 month |
|---|---|
| 2025-12-31 | -851.00K EUR 20-F · filed 2026-04-01 |